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The methyl-binding protein gene, MECP2, is a candidate
for involvement in autism through its implication as
a major causative factor in Rett syndrome that has
similarities to autism. Rare mutations in MECP2 have
also been identified in autistic individuals. We have
examined the possible broader involvement of MECP2
as a predisposing factor in the disorder. Analysis of
polymorphic markers spanning the gene and comprising
both microsatellites and single nucleotide polymor-
phisms (SNPs) by the transmission disequilibrium test
in two collections of families (219 in total), one in the
USA and one in the UK, has provided evidence for
significant association (P 5 0.009) for a three-marker
SNP haplotype of MECP2 with autism/autism spectrum
disorders. This association is supported by association of
both Single Sequence Repeat (SSR) and SNP single
markers located at the 30 end of the MECP2 locus and
flanking sequence, the most significant being that of an
indel marker located in intron 2 (P 5 0.001 – Bonferroni
corrected P 5 0.006). This suggests that one or more
functional variants of MECP2 existing at significant
frequencies in the population may confer increased risk
of autism/autism spectrum disorders and warrants fur-
ther investigation in additional independent samples.
Keywords: Autism, autism spectrum disorder, MECP2, poly-
morphisms, X-chromosome
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Autism is a neurodevelopmental disorder characterized by
social and communication impairments, coupled with stereo-
typed and repetitive behaviours. It is far more common in
males (4–10:1 male:female ratio; Folstein & Rosen-Sheidley
2001). Linkage studies have provided only weak evidence for
the involvement of X-linked loci but have limited power to
detect those of small effect size (Freitag 2007). Gauthier et al.
(2006) have provided some evidence for the involvement of
a locus at Xq27-q28 in the disorder employing both linkage
and association, and rare mutations in X-linked genes such as
neuroligin 3 (NLGN3) and neuroligin 4 (NLGN4) have also
been reported to be associated with autism (Jamain et al.
2003).
Rett syndrome (RTT) is an X-linked neurodevelopmental
disorder, with a prevalence of around 1 per 10 000–15 000
(Hagberg 1985; Hagberg & Hagberg 1997; Leonard et al.
1997). Many symptoms, including impaired language, stereo-
typic behaviours, high frequency of seizures and sleep
abnormalities as well as the developmental timing are com-
mon to both RTT and autism. Indeed, misdiagnosis of RTT
individuals as autistic can occur (Abdul-Rahman & Hudgins
2006; Moretti et al. 2005). Both disorders are grouped under
the heading of pervasive developmental disorders (PDD) in
Diagnostic and Statistical Manual of Disorders-IV (DSM-IV).
The MECP2 gene (Xq28) encodes the methyl-CpG-binding
protein 2 (MECP2), and mutations in the gene are reported to
be responsible for around 75% of cases of classical RTT.
Methyl-CpG-binding protein 2 protein binds to methylated
CpGs and is believed to repress the transcription of down-
stream genes, e.g. Bdnf in mice (Chen et al. 2003; Lewis et al.
1992; Meehan et al. 1992; Moretti & Zoghbi 2006); however,
there is evidence that the situation is more complex with
opposite directions of regulation existing in different tissues
(LaSalle 2007).MECP2 comprises four exons, with the coding
sequence shared among exons 2, 3 and 4 and a highly
conserved 30 untranslated region (UTR) of 8.5 kb (Coy et al.
1999). Both increases and decreases in MECP2 expression
have been implicated in a range of PDDs including autism
suggesting that a common pathway may be involved in these
disorders (Samaco et al. 2004, 2005; Van Esch et al. 2005).
Although they are rare, mutations in the coding region of
MECP2 have been observed in autistic individuals (Beyer
et al. 2002; Carney et al. 2003; Lam et al. 2000; Lobo-
Menendez et al. 2003; Vourc’h et al. 2001). Other studies
by Shibayama et al. (2004) detected one missense and two 30
UTR variants in 24 autism patients vs. only one missense
mutation in 144 ethnically matched individuals without
autism. Recently, Liu and Francke (2006) showed that certain
sequence motifs, distributed over a distance of 130 kb in and
around the MECP2 gene, make up a ‘functional expression
module’ containing enhancers and silencers. These interact
with the MECP2 promoter and affect the tissue-specific,
developmental stage-specific or splice-variant-specific control
of MECP2 protein expression.
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Thus, variations throughout the coding and non-coding
regions of the MECP2 gene, as well as flanking regions,
could be important factors contributing to the complex
disorder of autism. This study was designed to investigate
a series of polymorphic variants in theMECP2 gene, including
flanking and intronic regions, as potential markers for the
disorder by transmission disequilibrium tests (TDTs) in two
series of autistic families.
Methods
The DNA was available from 219 families with an affected autism
spectrum disorder proband, some of their siblings (n ¼ 81) and one
or both the proband’s parents (219 mothers and 196 fathers). The
sample collections taken from two main sources are as follows.
Molecular Genetics of Autism Study collection
These 121 families were mainly families in which the proband was
diagnosed by the National Specialist service multidisciplinary team at
the Michael Rutter Centre, South London and Maudsley (SLAM) NHS
Trust, London, UK. Some additional probands were included in this
sample from three other sources: Dr Anne O’Hare at Edinburgh
University; Dr A. J. Sharma at the Mary Sheridan Child Development
Centre, Camberwell and The Behaviour Genetics Clinic, SLAM NHS
Trust (young people with autism spectrum disorders). Cases with an
autism spectrum disorder (which was defined as a case with autistic
disorder, atypical autism, Asperger’s syndrome, pervasive develop-
mental disorder and others) were included. Diagnoses were made by
experienced clinicians following multidisciplinary assessments ac-
cording to ICD-10 criteria and wherever possible with the assistance
of structured parent interviews and semi-standardized observational
assessments [the Autism Diagnostic Interview (ADI-R; Lord et al.
1994) or an updated version of the Development and Wellbeing As-
sessment (Goodman et al. 2000) and/or the Autism Diagnostic
Observational Schedule (ADOS); n ¼ 70]. Cases were excluded if they
had another known, possible autism-causing medical condition (e.g.
fragile X syndrome or tuberous sclerosis) or if their IQ was below 35.
Autism Genetic Resource Exchange collection
This sample (n ¼ 98 families) is a subset of the sample collected for
the Autism Genetic Resource Exchange (AGRE) (Geschwind et al.
2001) with the support of the Cure Autism Now (http://www.cureau-
tismnow.org: now merged with Autism Speaks – http://www.autism-
speaks.org) under the direction of a scientific steering committee (see
websites). The DNA used in this study is from trios with an affected
proband and was collected for the initial purposes of screening. All
probands meet the criteria for autism spectrum disorder in one of
three categories: (1) autism diagnosed using the ADI-R, (2) Not Quite
Autism (NQA), where individuals are not more than one point away
from meeting autism criteria on any or all the three ‘content’ domains
(i.e. social, communication and non-social behaviour) andmeet criteria
for the ‘age of onset’ domain or who meet criteria on all three
‘content’ domains but not on the ‘age of onset’ domain and (3) broad
spectrum where individuals who showed patterns of impairment
along the spectrum of PDD. This is a broad diagnostic category and
encompasses PDDs such as Asperger’s syndrome. It is operationally
defined according to domain scores on the ADI algorithm and includes
cases who show (1) severe deficit in at least one domain, (2) more
moderate deficits in at least two domains and (3) only minimal deficits,
but in all three domains.
Diagnoses were confirmed using the ADI-R (Lord et al. 1994) and/or
the ADOS in 140 cases. In total, therewere 170 caseswith a diagnosis
of autism and 1 case with NQA, and 38 with a broad-spectrum
diagnosis [13 from the AGRE sample and 25 from the Molecular
Genetics of Autism Study (MGAS) sample]. Genotypic data were
available on 715 individuals. This included 219 autism spectrum
disorder probands, 81 siblings and 415 parents.
Genotyping
Microsatellite genotyping and analysis was set up and performed in-
house. Using the University of California Santa Cruz (UCSC) Genome
Browser, four microsatellite repeats were identified in the MECP2
gene whose properties suggested that they were likely candidates to
be variable in the population. Primers were designed using Primo
Multiplex to flank all four of these loci, and initial polymerase chain
reactions (PCRs) were carried out using standard conditions to
investigate heterozygosity in around 20 samples of female control
DNA. Two of the four markers were extensively polymorphic and
therefore informative. These markers were PCR amplified in separate
25 ml reactions using different template DNA concentrations, anneal-
ing temperatures and magnesium chloride concentrations (40 ng
DNA, 3.5 mM MgCl2 and 59.38C for marker 1 and 20 ng DNA,
2.5 mM MgCl2 and 568C for marker 2). The PCR products from the
single reactions were multiplexed for loading onto an ABI prism 3100
Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Micro-
satellite marker 1 was an AT dinucleotide repeat located at
chrX:152823442. Marker 2 was a GT dinucleotide repeat located at
chrX:152832198. These are both loci within the large intron 2 in the
MECP2 gene (Fig. 1).
Six single nucleotide polymorphisms (SNPs) were selected initially,
using HAPLOVIEW version 3.2, on the basis of their having minimum
allele frequencies predicted to be high enough to be informative
(>0.05) and locations that were spread across the gene and capable
of capturing variation in the single block of linkage disequilibrium (LD)
across the whole gene. These SNPs (for which one assay failed) were
genotyped at K Biosciences (Hoddesdon, UK; http://www.kbioscien-
ce.co.uk). The five SNPs for which data were obtained are from 30 to
50: (1) rs5945173 (A/G), chrX:152771019; (2) rs11465839 (C/T), chrX:
152801114; (3) rs2734647 (C/T), chrX:152813027; (4) rs5945175 (C/
T), chrX:152879604 and (5) rs5945397 (A/G), chrX:152894373 (Fig. 1).
Genotyping success rates achieved by the company varied between
93% and 97% for female samples and between 95% and 97% for
male samples with an exception being rs5945173, where the success
rate was 90%. This SNP was of low information content in
Figure 1: Diagram of MECP2 gene
(andneighbouring IRAK1 gene in grey),
with positioning of markers selected in
this study shown beneath (not to
scale). The exons are filled in black and
are labelled 1–4 from 50 to 30. SNP 1 ¼
rs5945173; SNP 2 ¼ rs11465839; SNP
3 ¼ rs2734647; SNP 4 ¼ rs5945175 and
SNP 5 ¼ rs5945397. F numbers above
gene indicate regulatory regions identi-
fied by Liu and Francke (2006) – F3 and
F13 are silencers and F11 and F17 are
enhancers.
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transmission analysis, and although it was included in the preliminary
analysis, its contribution to the final haplotype analysis was minimal.
Allele frequencies were calculated separately for males and females
and showed no significant differences (P > 0.6). All SNPs examined
were in Hardy–Weinberg equilibrium with P > 0.05 after correction
for multiple testing, apart from rs2734647 (P ¼ 0.011). The five SNPs
cover the region defined as the ‘MECP2 functional expression
module’ (Liu & Francke 2006). SNPs rs2734647, rs5945175 and
rs5945397 and the Single Sequence Repeat (SSR) markers are within
a block of high LD covering the MECP2 locus, and SNPs rs5945173
and rs11465839 are located on either side of the 30 enhancer region F17.
Based on May 2004 assembly release, the co-ordinates of the
MECP2 region (which includes the IRAK1 locus which abuts the 30
region of MECP2 and overlaps the enhancers examined) were
chrX:152,789,145-152,902,943. The tag SNPs selected capture
94% of the known variation at r2 ¼ 0.8 within this region (http://
www.broad.mit.edu/mpg/tagger/) based on HAPMAP Build 35
release 21a/phase II jan 07 on NCBI B35 assembly dpSNP 125. The
Centre d’Etude du Polymorphisme Humain Collection-European
(CEPH CEU) population was examined by pairwise tagging.
Analysis
Distortion in the transmission of microsatellite and SNP alleles was
tested for by the TDT implemented in TDTPHASE from the UNPHASED
version 2.404 (2003) suite of programs (Dudbridge 2003). Analysis
was stratified by sample collection, sex and phenotypic subgroups.
For microsatellite 1, alleles were clumped using the program NOCOM
version 20 (April 2007) (Ott 1979) to estimate the best fitting normal
distributions for observed allele counts.
Results
Microsatellites
Data were analysed using the TDT for deviations from ex-
pected random inheritance of alleles by offspring, which may
indicate their tracking of predisposing or protective variants of
the gene. Once data with any Mendelian errors or missing
information had been removed, 219 affected families were
available for analysis with both markers employing TDTPHASE.
For SSR marker 1, an inspection of the pattern of allele
frequencies indicated that allele sizes approximated to a tri-
modal distribution, suggesting that the three groups (num-
bered 1–3) contained alleles that may be closely related in
evolutionary terms by replication slippage. Examining the fit
of the allele size and frequency data to one or more normal
distributions employing the program NOCOM (Ott 1979) indi-
cate that two distributions fit significantly better than one and
three distributions significantly better than two (P ¼ <
0.0001) centring on mean allele sizes of 212, 228 and
240 bp with frequencies of 0.76, 0.18 and 0.06 (Fig. 2).
As an expedient to reduce the requirement for conservative
multiple testing, we therefore analysed the frequencies of the
three size groups by TDT. This indicated that allele group 1 is
over-transmitted to the probands in the combined sample
(P ¼ 0.021), while allele group 2 shows a trend to be under-
transmitted to the probands (P ¼ 0.073) (Table 1).
Analyses for marker 1 were also carried out on each sample
(AGRE andMGAS) separately to see if one cohort was driving
the pattern of results (Table 1). As shown, the strongest
significance was found in the AGRE sample for the under-
transmission of allele group 2 (P ¼ 0.010), followed by over-
transmission of allele group 1 (P ¼ 0.018), with the MGAS
samples following the same pattern of over-transmission for
allele group 1, although the figures are not significant.
The distribution of the allele sizes was also examined for
marker 2; however, there was no obvious division into allele
Figure 2: Distribution of marker 1 alleles
(measured in base pairs of the amplicon)
and the three groups into which they
were categorized for further TDT analysis
of clumped alleles. Allele lengths are in base
pairs and their means within each of the
three groups.
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size groupings that would have enabled simplification of the
analysis. Nevertheless, it appeared that although the original
sequence analysis of marker 2 indicated it to be a dinucleotide
repeat (with consecutively sized products that are presump-
tively 2 bp different from one another), there were a sub-
stantial number (n ¼ 101) of alleles representing nine
different sizes separated by 1 bp from the dinucleotide peaks
(data not shown). As the amplification method had been
designed to eliminate problems with the sporadic addition of
an extra nucleotide (plus-A) (Brownstein et al. 1996), the
possibility that these additional alleles represented indepen-
dent alleles was therefore investigated. It was subsequently
found from the published sequence that the amplified region
between the primers for marker 2 also contains a single base
pair indel polymorphism G/- (rs11348580) in a string of G
residues located 3 bp 30 to the dinucleotide repeat, which
created two allelic series separated by 1 bp. Unfortunately,
the sequence surrounding the indel precluded a simple PCR-
based genotyping assay. We decided, therefore, to analyse
the transmittance and non-transmittance of alleles with and
without a G deletion indirectly by comparing products with an
odd number vs. products with an even number of base pairs
(Table 2). The alleles of the indel employing this indirect assay
were in Hardy–Weinberg equilibrium (P > 0.05 after correc-
tion for multiple testing). As indicated, even-sized alleles (no G
deletion) were significantly over-transmitted, while odd-sized
alleles (G deletion) were significantly under-transmitted (P ¼
0.001). A TDT was also carried out for this single base pair
deletion allele in theMGAS and AGRE samples separately. As
shown in Table 2, the MGAS samples showed a significant
over-transmission of the even-sized (no deletion) allele (P ¼
0.039), and although this over-transmission was not significant
for the AGRE sample (P ¼ 0.103), the bias was again for the
even-sized allele to be transmitted more often (75 transmitted
vs. 65 not transmitted). Because the over-transmission of the
even-sized allele was at its most significant when the MGAS
and AGRE samples were combined (P ¼ 0.001), it appears
that the finding is consistent in both cohorts.
Single nucleotide polymorphisms
The distribution of the five successfully genotyped SNPs
across the MECP2 locus is shown in Fig. 1. As was the case
for microsatellites, TDT analysis of the SNP data was carried
out using TDTPHASE (Table 3). The data for the two samples
combined indicated that SNPs rs5945173 and rs2734647
were significantly biased in transmission (P ¼ 0.006 and
P ¼ 0.016, respectively). Evidence for the remaining
SNPs was compromised by the low frequencies of the rarer
alleles – in spite of our preliminary selection for minor allele
frequencies to be >0.05 – the frequencies for SNPs
rs11465839, rs5945175 and rs594539 that we observed
were only between 0.01 and 0.04, and consequently, few
informative transmissions were available for analysis, and
they were not considered from the viewpoint of multiple
testing. When the AGRE and MGAS cohorts were analysed
separately, the same markers were significant in the AGRE
cohort (rs5945173, P ¼ 0.003 and rs2734647, P ¼ 0.008).
Analysis of MGAS data alone did not show significance for the
two SNPs that were significant in the AGRE sample, although
the direction of the biased transmission in the AGRE sample
was weakly echoed.
Application of a Bonferroni correction for multiple testing of
the indel and the two usefully informative SNPs together with
the microsatellite SSR marker 1 reduces the probability for
association in the combined samples as follows: indel
rs11348580 (0.004), rs5945173 (0.024) and rs2734647
(0.064) leaving the indel and rs5945173 significant and
rs2734647 showing a trend to significance.
To investigate the effect of using narrower phenotypic
criteria, TDT analysis was repeated on the combined sample
Table 1: TDT analysis for SSRmarker 1 alleles grouped into three
allele categories
Allele T Freq-T NT Freq-NT T (%) Chi-square P value
AGRE and MGAS combined (SSR marker 1 alleles grouped into
three categories)
1 169 0.81 150 0.71 52.98 5.3 0.021
2 32 0.15 45 0.21 41.56 3.22 0.073
3 9 0.04 15 0.07 37.5 1.52 0.218
AGRE only (SSR marker 1 alleles grouped into three categories)
1 77 0.80 64 0.67 54.61 5.62 0.018
2 14 0.15 27 0.28 34.15 6.53 0.010
3 5 0.05 5 0.05 50 0 1
MGAS only (SSR marker 1 alleles grouped into three categories)
1 92 0.81 86 0.75 51.69 0.95 0.329
2 18 0.16 18 0.16 50 0 1
3 4 0.04 10 0.09 28.57 2.66 0.103
Allele, allele category; T, number of times allele is transmitted to
affected offspring, Freq-T, frequency allele is transmitted; NT, number
of times allele not transmitted to affected offspring; Freq-NT, fre-
quency allele is not transmitted; T (%), percentage of transmissions
(of total transmissions and non-transmissions); Chi-squared, chi-
squared statistic.
Table 2: TDT analysis for the indel associated with SSRmarker 2
comparing alleles with and without G deletions (‘odd’ and ‘even’,
respectively)
Allele T Freq-T NT Freq-NT T (%) P value
AGRE and MGAS combined, SSR marker 2 (indel rs11348580)
Even 174 0.82 153 0.72 53.21 0.001
Odd 39 0.18 60 0.28 39.39
AGRE sample only, SSR marker 2
Even 75 0.77 65 0.6 53.57 0.103
Odd 23 0.23 33 0.34 41.07
MGAS samples only, SSR marker 2
Even 99 0.86 88 0.77 52.94 0.039
Odd 16 0.14 27 0.23 37.21
Allele, allele size; T, number of times allele is transmitted to affected
offspring; Freq-T, frequency allele is transmitted; NT, number of times
allele not transmitted to affected offspring; Freq-T, frequency allele is
not transmitted, T (%), percentage of transmissions (of total trans-
missions and non-transmissions), Chi-square, chi-squared statistic.
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after removing all families in which the proband was allotted
a broad-spectrum diagnosis. This left only families where the
proband had a pure ‘autism’ or an ‘Asperger’s syndrome’
diagnosis. Asperger’s individuals were still included in the
narrow phenotype sample both to maintain a relatively large
sample size and because their social interactions are as
severely impaired as they are for autistic individuals. We have
previously indicated the importance of X-linked loci to the
social substrate of the autistic phenotype (Loat et al. 2004)
and, therefore, all probands for whom the diagnosis implied
a level of deficit in social functioning equivalent to autism
were analysed. Analysis of the data after the removal of the
less severe phenotypic group of probands (which included 39
individuals, most of whom had a PDD nitric oxide synthase
diagnosis) marginally increased the significance of rs5945173
(P ¼ 0.002) and rs2734647 (P ¼ 0.006).
Haplotype analysis for rs5945173 and rs2734647 (i.e. those
with appreciable heterozygosity, c. 30%) indicated that the
G-C haplotype was significantly over-transmitted (P ¼ 0.011)
and the A-T haplotype was significantly under-transmitted
(P ¼ 0.021). When the LD patterns at the rare SNPs are also
included to determine if this can subdivide the common G-C
haplotype using the whole panel of five SNPs (numbered in
order from 30 to 50 – Fig. 1) this showed that the G-T-C-T-G
haplotype was significantly over-transmitted (P ¼ 0.004),
while the A-T-T-T-G haplotype was under-transmitted P ¼
0.032) from parents to autistic offspring (Table 4). If the use-
fully informative SNPmarkers (rs5945173 and rs2734647) are
combined with the indel within SSR marker 2, the haplotype
significance for over-transmission for G-C odd is 0.009. Given
the patterns of significance for the SSR marker 1, the indel
and SNPs, it appears that any functional variant associated
with autism and tracked by these may be located towards the
30 end of the gene.
Discussion
The possibility thatMECP2 variants may be involved in autism
has been suggested by previous research identifying a clear
association between mutations inMECP2 and RTT and by the
acknowledgement of an overlap in behavioural phenotypes
and gene expression profiles in brain tissue from RTT and
autistic individuals. Furthermore, there is some evidence
suggesting that mutations in the coding, and 30 UTRs of
MECP2 may be associated with the disorder (Carney et al.
2003; Lam et al. 2000; Shibayama et al. 2004). Recent
evidence additionally suggests that regions of the genome
within and near to the MECP2 locus harbour regulatory
elements affecting its transcription (Liu & Francke 2006).
The study reported here aimed to investigate whether there is
evidence for a bias in the transmission, from parents to
autistic offspring in two different sample collections, of
particular alleles at several polymorphic sites in and around
MECP2. Data from twomicrosatellites located in intron 2, and
five SNPs within, upstream and downstream of the gene
were analysed. Our results indicate that one or more rela-
tively common variants in MECP2 may play some part in
altering the risk for autism. Of the two highly polymorphic
microsatellite markers we investigated, one gave a significant
bias in transmission to probands when alleles were grouped
based on clusters of sizes closely approximating to three
normal distributions, the groups themselves being distinct
from each other. The other microsatellite, while not signifi-
cant itself, was located in close proximity to a single base pair
deletion (rs11348580), which could be detected using the
same microsatellite assay, and this single base pair insertion/
deletion showed a significant association with autism in the
combined sample.
Table 3: TDT results for all five MECP2 SNPs on combined
sample
MGAS and AGRE combined
SNP Allele T Freq-T NT Freq-NT T (%) P value
1 A 31 0.16 51 0.27 37.8 0.006
G 161 0.84 141 0.73 53.31
2 C 5 0.02 7 0.03 41.67
T 199 0.98 197 0.97 50.25
3 C 179 0.86 162 0.78 52.49 0.016
T 30 0.14 47 0.22 38.96
4 C 2 0.01 3 0.02 40
T 187 0.99 186 0.98 50.13
5 A 5 0.03 9 0.05 35.71
T 183 0.97 179 0.95 47.5
T, number of times allele is transmitted to affected offspring; Freq-T,
frequency allele is transmitted; NT, number of times allele not
transmitted to affected offspring; Freq-T, frequency allele is not
transmitted; T (%), percentage of transmissions (of total transmis-
sions and non-transmissions); Chi-square, chi-squared statistic.
SNPs are labelled 1–5 from 30 to 50 as follows: 1: rs5945173 (A/G); 2:
rs11465839 (C/T); 3: rs2734647 (C/T); 4: rs5945175 (C/T),
chrX:152879604; 5: rs5945397 (A/G), chrX:152894373. P values not
included forMECP2 SNPs 2, 4 and 5 as there is less than 50% power
to detect a variant of 5% frequency conferring an allele-specific risk of
1.7; this rising to >80% for alleles with frequencies >12% (http://
pngu.mgh.harvard.edu/~purcell/gpc/).
Table 4: Haplotype TDT results for all five SNPs
Haplotype T Freq-T NT Freq-NT T (%) Chi-square P value
A-T-C-T-G 4 0.07 8 0.15 33.33 1.359 0.244
A-T-T-C-A 1 0.02 3 0.05 25 1.046 0.306
A-T-T-T-A 2 0.04 4 0.07 33.33 0.6796 0.410
A-T-T-T-G 8 0.15 19 0.76 29.63 4.615 0.032
G-C-C-T-G 3 0.05 5 0.09 37.5 0.5053 0.477
G-T-C-T-G 35 0.64 15 0.27 70 8.228 0.004
G-T-T-T-G 2 0.04 1 0.02 66.67 0.3398 0.560
T, number of times allele is transmitted to affected offspring; Freq-T,
frequency allele is transmitted; NT, number of times allele not
transmitted to affected offspring; Freq-T, frequency allele is not
transmitted; T (%), percentage of transmissions (of total transmis-
sions and non-transmissions); Chi-square, chi-squared statistic.
Alleles are listed in order for SNPs 1–5 in a 30 to 50 direction.
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Our SNP analyses also generated interesting results. While
the most significant findings arose when one of the samples
(AGRE) was considered in isolation, the two apparently
associated SNPs (rs5945173 and rs2734647) continued to
be significantly associated in the combined sample. While the
data for the other SNPs examined did not suggest significant
association, the low frequencies of the minor alleles resulted
in relatively few informative transmissions. The reason for the
difference between the strength of findings in the AGRE and
MGAS samples is not clear but may be influenced by the fact
that they were collected in different countries and diagnosed
against slightly different criteria. Both samples were primarily
made up from cases meeting clinical/ADI-R criteria for autism
(79% MGAS and 86% AGRE). The slightly higher proportion
of cases meeting the criteria for autism in the AGRE sample
may be relevant, but the numbers in the samples were too
small to permit meaningful subgroup analyses.
The most significant of the SNP haplotypes made up of
varying numbers of SNPs was the five-marker G-T-C-T-G
haplotype, which was transmitted to autistic probands on
35 occasions and not transmitted on only 15 for the combined
sample. This may reflect the fact that there is strong LD in the
MECP2 gene and that any true association of a functional
variant with autism may be detected at some distance from
the real locus of interest. The results of SNP analysis based
on rs5945173 and rs2734647, which had relatively frequent
minor alleles, indicated that theywere significantly associated
with autism both individually and as a haplotype. Further-
more, the combined haplotype for rs5945173 and rs2734647
and the indel within SSR marker 2 was also significantly
associated (P ¼ 0.009). This might imply that the 30 end of
the gene is more likely to track the truly functional variant.
However, given the low number of informative transmissions
for the other SNPs, it is conceivable that this concentration of
significant findings at the 30 end simply results from greater
power to detect significance at these more informative loci.
The data from the MECP2 microsatellites and five SNPs
were not incorporated into the same haplotype analyses
because the nature of LD between these disparate types of
markers is unknown and so the validity of such an approach to
identify which specific region of a gene is of most interest is
questionable. Nevertheless, it is reassuring that significant
associations were observed with both SNPs and microsatel-
lite/indel, and associations observed in one sample group
were generally supported by trends in the same direction
observed for the other group. It is reasonable to assume that
true associations will be detected by single marker analysis,
and this would suggest that the 30 end of the MECP2 gene
might be playing a role in vulnerability to autism. Given the
concentration of Liu and Francke’s regulatory regions in this
area, it is entirely possible that one or more functional
polymorphisms in and around this end of the gene might be
of importance. Furthermore, the observation of the functional
importance of microRNA recognition elements located in the
30 UTR of the long transcript of the gene, which is the
predominant form in brain, adds support to this interpretation
(Klein et al. 2007).
Further studies using other large autistic samples with clear
inclusion criteria would help to clarify these findings. Overall,
our results suggest that MECP2 may well be a predisposing
factor for autism. Certainly the gene has an impressive list of
credentials for involvement in behavioural disorders. An
intriguing recent report suggests, for example, that MECP2
interacts with ATRX (X linked) and that point mutations within
the methylated DNA-binding domain of MECP2 can disrupt
this interaction in vitro and in vivo (Nan et al. 2007). ATRX has
been implicated in a range of X-linked mental retardation
syndromes (OMIM 300032). Furthermore, the involvement of
the key neuronal growth factor gene, Bdnf, as a target (Chen
et al. 2003) further points to MECP2’s potential involvement
in important aspects of brain development. Most recently,
the introduction of a conditional Mecp2 allele with only 50%
activity into mice (Mecp2Flox/y) was observed to result in a
spectrum of abnormalities including learning and motor
deficiencies and altered social behaviour, indicating that more
subtle changes in MeCP2 activity may have a significant
behavioural impact (Samaco et al. 2008).
Clearly, autism is a disorder with complex genetic aetiol-
ogy, andMECP2 is a gene with wide-ranging interactions and
mechanisms of effect. It is vital, therefore, that we incorpo-
rate sufficient complexity into our models for understanding
in detail howMECP2 and its gene partners might be involved
in vulnerability to autism.
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